Anesth Analg 2006;103:478-483
© 2006 International Anesthesia Research Society
doi: 10.1213/01.ane.0000223847.50233.1b
PAIN MEDICINE
Propofols Effects on Nociceptive Behavior and Spinal C-Fos Expression After Intraplantar Formalin Injection in Mice with a Mutation in the Gamma-Aminobutyric Acid-TypeA Receptor ß3 Subunit
Austin W. Merrill, BS*,
Linda S. Barter, MVS ,
Uwe Rudolph, MD ,
Edmond I. Eger, II, MD ,
Joseph F. Antognini, MD* ,
Mirela Iodi Carstens, BA*, and
E. Carstens, PhD*
From the *Section of Neurobiology, Physiology and Behavior, Department of Anesthesiology and Pain Medicine, University of California, Davis, California; McLean Hospital, Belmont, Massachusetts; and the Department of Anesthesiology and Perioperative Care, University of California, San Francisco, San Francisco, California.
Address correspondence and reprint requests to Earl E. Carstens, Section of Neurobiology, Physiology & Behavior, University of California, Davis, Davis, California, 95616. E-mail: eecarstens{at}ucdavis.edu.
We investigated whether propofol affected nociceptive behavior and fos-like immunoreactivity (FLI) in the lumbo-sacral spinal cord after intraplantar formalin injection in wild-type (WT) mice and in mutant mice harboring a point mutation of the gamma-aminobutyric acid type A receptor, which renders them resistant to propofol. Bolus injection of propofol (30 mg/kg IV) in WT mice reduced phase 1 formalin-evoked behavior over the initial 23 min but did not alter phase 2 behavior or spinal FLI (64 ± 19 cells/section) compared with WT mice receiving intralipid vehicle plus intraplantar formalin (57 ± 19 cells/section). Most FLI was restricted to superficial dorsal horn laminae ipsilateral to the formalin injection. WT mice receiving a 60-min propofol infusion were anesthetized throughout and did not display nociceptive behavior but had FLI (58 ± 11 cells/section) that did not differ significantly from the other WT groups. Mutant mice receiving bolus injection of propofol (30 mg/kg) and intraplantar formalin were not anesthetized and exhibited nociceptive behavior. The total FLI in the spinal cord was 47 ± 29 cells/section. These data indicate that although propofol produces anesthesia, it does not prevent the FLI that is associated with nociception, a finding consistent with propofol lacking analgesic properties.
This article has been cited by other articles:

|
 |

|
 |
 
T. Akiyama, A. W. Merrill, K. Zanotto, M. I. Carstens, and E. Carstens
Scratching Behavior and Fos Expression in Superficial Dorsal Horn Elicited by Protease-Activated Receptor Agonists and Other Itch Mediators in Mice
J. Pharmacol. Exp. Ther.,
June 1, 2009;
329(3):
945 - 951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Akiyama, A. W. Merrill, M. I. Carstens, and E. Carstens
Activation of Superficial Dorsal Horn Neurons in the Mouse by a PAR-2 Agonist and 5-HT: Potential Role in Itch
J. Neurosci.,
May 20, 2009;
29(20):
6691 - 6699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fassoulaki, A. Melemeni, A. Paraskeva, I. Siafaka, and C. Sarantopoulos
Postoperative Pain and Analgesic Requirements After Anesthesia with Sevoflurane, Desflurane or Propofol
Anesth. Analg.,
November 1, 2008;
107(5):
1715 - 1719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. I. Eger II, D. E. Raines, S. L. Shafer, H. C. Hemmings Jr, and J. M. Sonner
Is a New Paradigm Needed to Explain How Inhaled Anesthetics Produce Immobility?
Anesth. Analg.,
September 1, 2008;
107(3):
832 - 848.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|